← Evidence map

ArticleJournal of the Pediatric Orthopaedic Society of North America2025

Fosaprepitant Use as an Antiemetic to Prevent Postoperative Nausea and Vomiting in Pediatric Spinal Fusion Patients May Be Associated With More Rapid Transition to Oral Pain Medication and Reduced Length of Stay.

Jennifer Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Fosaprepitant Use as an Antiemetic to Prevent Postoperative Nausea and Vomiting in Pediatric Spinal Fusion Patients May Be Associated With More Rapid Transition to Oral Pain Medication and Reduced Length of Stay. | OpenQuestion